IMCR Earnings Immunocore Holdings Plc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–15 of 15
| Q1 2026 | 2026-03-31 | 0.25 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -0.71 | 2026-02-25 | 10-K |
| Q3 2025 | 2025-09-30 | -0.11 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.11 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.10 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -1.02 | 2026-02-25 | 10-K |
| Q3 2025 | 2024-09-30 | -0.55 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.72 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.49 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | -1.13 | 2026-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -0.73 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.75 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.40 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -1.15 | 2025-02-26 | 10-K |
| FY 2023 | 2021-12-31 | -4.24 | 2024-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.